Skip to navigation Skip to content

A Trial of Vitamin D and Copaxone in Patients with Relapsing MS

Share

Details

Washington University School of Medicine
660 South Euclid Ave.
St. Louis, MO 63110
See Map

Summary
This research study will evaluate whether Vitamin D when given with Copaxone reduces the rate of relapse in 2 years. Eligible Participants will be randomized to receive either low dose or high dose vitamin D (oral) with Copaxone. Copaxone and Vitamin D are provided as part of the study.
 
Participant Criteria
18-50 years of age with a diagnosis relapsing MS who have had 1 attack and one or two new lesions on MRI in the past year, or have had 2 clinical attacks within the last 2 years which one of was in the past year.
 
Length of Trial:  2 years
 
Location of Trial: John L. Trotter MS Center, Washington University School of Medicine
 
Clinical Trial Sponsor: National MS Society
 
Contact
Susan Fox, Research Patient Coordinator/Professional
314-362-2017

Share


Chapter HomeReturn to list
© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.